Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main Cara Therapeutics, Inc. Transaction History

Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main

$88.7 Billion
Q1 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 17, 2024	BUY	$4.89 - $12.27 $132 - $331	27 New	27 $0
Q1 2023 May 15, 2023	BUY	$4.89 - $12.27 $132 - $331	27 New	27 $0
Q2 2018 Aug 14, 2018	SELL	$11.6 - $19.27 $928,000 - $1.54 Million	-80,000 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$11.77 - $16.08 $941,600 - $1.29 Million	80,000 New	80,000 $990,000

Others Institutions Holding CARA

# of Institutions

102

Shares Held

21.5M

Call Options Held

50K

Put Options Held

Black Rock Inc. New York, NY

3.42M
Shares

$889,554
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

2.48M
Shares

$645,127
0.0% of portfolio
Disciplined Growth Investors Inc Minneapolis, MN

1.82M
Shares

$471,915
0.03% of portfolio
Chescapmanager LLC Baltimore, MD

1.7M
Shares

$442,548
0.15% of portfolio
Farallon Capital Management LLC San Francisco, CA

1.56M
Shares

$404,625
0.01% of portfolio

View Full List

About Cara Therapeutics, Inc.

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $14M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

More about CARA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main, based on Form 13F filings with the SEC.

News

Stay updated on Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main with notifications on news.

Account